Advertisement

Topics

Boehringer Ingelheim selling molecules, crowdsourcing research proposals

09:22 EST 21 Nov 2017 | Outsourcing-Pharma

Boehringer Ingelheim has launched a new platform through which it will offer open access to selected preclinical molecules in order to 'unlock the full potential' of compounds no longer under development by the company.

Original Article: Boehringer Ingelheim selling molecules, crowdsourcing research proposals

NEXT ARTICLE

More From BioPortfolio on "Boehringer Ingelheim selling molecules, crowdsourcing research proposals"

Quick Search
Advertisement